Medication Guide — Noxafil

This Patient Information has been approved by the U.S. Food and Drug Administration.                                                              Revised: 1/2026

NOXAFIL

(

-a-fil)

(posaconazole) injection

NOXAFIL

(

-a-fil)

(posaconazole) delayed-release tablets

NOXAFIL

(

-a-fil)

(posaconazole) oral suspension

NOXAFIL

(

-a-fil) POWDERMIX

(posaconazole) for delayed-release oral suspension

What is Noxafil and Noxafil PowderMix?
Noxafil (which refers to injection, delayed-release tablets, and oral suspension) and Noxafil PowderMix (for delayed-release oral suspension) are prescription medicines used in adults and children to help prevent or treat fungal infections that can spread throughout your body (invasive fungal infections). These infections are caused by fungi called Aspergillus or Candida. Noxafil and Noxafil PowderMix are used in people who have an increased chance of getting these infections due to a weak immune system. These include people who have had a hematopoietic stem cell transplantation (bone marrow transplant) with graft versus host disease or those with a low white blood cell count due to chemotherapy for blood cancers (hematologic malignancies).

Noxafil injection is used for:

• prevention of fungal infections in adults and children 2 years of age and older who weigh 22 lbs (10 kg) or greater.
• treatment of fungal infections in adults and children 2 years of age and older who weigh 22 lbs (10 kg) or greater.

Noxafil delayed-release tablets are used for:

• prevention of fungal infections in adults and children 2 years of age and older who weigh greater than 88 lbs (40 kg).
• treatment of fungal infections in adults and children 2 years of age and older who weigh greater than 88 lbs (40 kg).

Noxafil oral suspension is used for:

• prevention of fungal infections in adults and children 13 years of age and older.

Noxafil PowderMix for delayed-release oral suspension is used for:

• prevention of fungal infections in children 2 years of age and older who weigh 22 lbs to 88 lbs (10 kg to 40 kg).
• treatment of fungal infections in children 2 years of age and older who weigh 22 lbs to 88 lbs (10 kg to 40 kg).

Noxafil oral suspension is also used to treat a fungal infection called “thrush” caused by Candida in your mouth or throat area. Noxafil oral suspension can be used as the first treatment for thrush, or as another treatment for thrush after itraconazole or fluconazole treatment has not worked.

Noxafil oral suspension is for adults and children 13 years of age and older.

It is not known if Noxafil oral suspension is safe and effective in children under 13 years of age for the treatment of thrush as the first treatment for thrush, or as another treatment for thrush after itraconazole or fluconazole treatment has not worked.

It is not known if Noxafil or Noxafil PowderMix is safe and effective in children under 2 years of age.

• are allergic to posaconazole, any of the ingredients in Noxafil or Noxafil PowderMix, or other azole antifungal medicines. See the end of this Patient Information leaflet for a complete list of ingredients in Noxafil and Noxafil PowderMix.
• are taking any of the following medicines:
  • sirolimus
  • pimozide
  • quinidine
  • certain statin medicines that lower cholesterol (atorvastatin, lovastatin, simvastatin)
  • ergot alkaloids (ergotamine, dihydroergotamine)
• have chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and you have just started taking venetoclax or your venetoclax dose is being slowly increased.
• are taking Noxafil PowderMix for delayed-release oral suspension and have hereditary fructose intolerance.

Ask your healthcare provider or pharmacist if you are not sure if you are taking any of these medicines.

Do not start taking a new medicine without talking to your healthcare provider or pharmacist.

• are taking certain medicines that lower your immune system like cyclosporine or tacrolimus.
• are taking certain drugs for HIV infection, such as ritonavir, atazanavir, efavirenz, or fosamprenavir. Efavirenz and fosamprenavir can cause a decrease in the Noxafil levels in your body. Efavirenz and fosamprenavir should not be taken with Noxafil or Noxafil PowderMix.
• are taking midazolam, a hypnotic and sedative medicine.
• are taking vincristine, vinblastine and other “vinca alkaloids” (medicines used to treat cancer).
• are taking venetoclax, a medicine used to treat cancer.
• have or had liver problems.
• have or had kidney problems.
• have or had an abnormal heart rate or rhythm, heart problems, or blood circulation problems.
• are pregnant or plan to become pregnant. It is not known if Noxafil will harm your unborn baby.
• are breastfeeding or plan to breastfeed. It is not known if Noxafil passes into your breast milk. You and your healthcare provider should decide if you will take Noxafil or breastfeed. You should not do both.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Noxafil and Noxafil PowderMix can affect the way other medicines work, and other medicines can affect the way Noxafil and Noxafil PowderMix work, and can cause serious side effects.
Especially tell your healthcare provider if you take:

• rifabutin or phenytoin. If you are taking these medicines, you should not take Noxafil delayed-release tablets, Noxafil oral suspension, or Noxafil PowderMix for delayed-release oral suspension.
• cimetidine or esomeprazole. If you are taking these medicines, you should not take Noxafil oral suspension.

Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure.
Know the medicines you take. Keep a list of them with you to show your healthcare provider or pharmacist when you get a new medicine.

How should I take Noxafil or Noxafil PowderMix?

• Do not switch between Noxafil oral suspension and Noxafil delayed-release tablets or Noxafil PowderMix for delayed-release oral suspension.
• Take Noxafil or Noxafil PowderMix exactly as your healthcare provider tells you to take it.
• Your healthcare provider will tell you how much Noxafil or Noxafil PowderMix to take and when to take it.
• Take Noxafil or Noxafil PowderMix for as long as your healthcare provider tells you to take it.
• If you take too much Noxafil or Noxafil PowderMix, call your healthcare provider or go to the nearest hospital emergency room right away.
• Noxafil injection is usually given over 30 to 90 minutes through a plastic tube placed in your vein.
• Noxafil delayed-release tablets:
  • Take Noxafil delayed-release tablets with or without food.
  • Take Noxafil delayed-release tablets whole. Do not break, crush, or chew Noxafil delayed-release tablets before swallowing. If you cannot swallow Noxafil delayed-release tablets whole, tell your healthcare provider. You may need a different medicine.
  • If you miss a dose, take it as soon as you remember and then take your next scheduled dose at its regular time. If it is within 12 hours of your next dose, do not take the missed dose. Skip the missed dose and go back to your regular schedule. Do not double your next dose or take more than your prescribed dose.
• Noxafil oral suspension:
  • Shake Noxafil oral suspension well before use.
  • Take each dose of Noxafil oral suspension during or within 20 minutes after a full meal. If you cannot eat a full meal, take each dose of Noxafil oral suspension with a liquid nutritional supplement or an acidic carbonated beverage, like ginger ale.
  • A measured dosing spoon comes with your Noxafil oral suspension and is marked for doses of 2.5 mL and 5 mL. See Figure A.
  • Rinse the spoon with water after each dose of Noxafil oral suspension and before you store it away.
  • If you miss a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and go back to the regular dosing schedule. Do not take a double dose to make up for the missed dose or take more than your prescribed dose.
• Noxafil PowderMix for delayed-release oral suspension:
  • Before giving the first dose of Noxafil PowderMix for delayed-release oral suspension, read the Instructions for Use booklet that comes with Noxafil PowderMix for delayed-release oral suspension for information about the correct way to mix and give a dose of Noxafil PowderMix for delayed-release oral suspension to your child. Keep the booklet and follow it each time you prepare the medicine. Bring this booklet to your child’s appointments.
  • If you have questions about how to mix or give Noxafil PowderMix, talk with your healthcare provider or pharmacist.
  • Only use the mixing liquid that comes with the kit to prepare Noxafil PowderMix.
  • After mixing, measure the prescribed dose with notched tip syringe provided with the kit. Only use the notched tip syringes that come with the kit to prepare and give the medicine.
  • Give the dose within 1 hour of mixing the suspension. Give with food.
  • If your child does not take all of the prescribed dose or spits some of it out, call your healthcare provider to find out what to do.

Follow the instructions from your healthcare provider on how much Noxafil or Noxafil PowderMix you should take and when to take it.

What are the possible side effects of Noxafil or Noxafil PowderMix?

Noxafil or Noxafil PowderMix may cause serious side effects, including:

• drug interactions with cyclosporine or tacrolimus. If you take Noxafil or Noxafil PowderMix with cyclosporine or tacrolimus, your blood levels of cyclosporine or tacrolimus may increase. Serious side effects can happen in your kidney or brain if you have high levels of cyclosporine or tacrolimus in your blood. Your healthcare provider should do blood tests to check your levels of cyclosporine or tacrolimus if you are taking these medicines while taking Noxafil or Noxafil PowderMix. Tell your healthcare provider right away if you have swelling in your arm or leg or shortness of breath.
• problems with the electrical system of your heart (arrhythmias and QTc prolongation). Certain medicines used to treat fungus called azoles, including posaconazole, the active ingredient in Noxafil and Noxafil PowderMix, may cause heart rhythm problems. People who have certain heart problems or who take certain medicines have a higher chance for this problem. Tell your healthcare provider right away if your heartbeat becomes fast or irregular.
• changes in body salt (electrolytes) levels in your blood. Your healthcare provider should check your electrolytes while you are taking Noxafil or Noxafil PowderMix.
• new or worsening high blood pressure and low potassium levels in your blood (pseudoaldosteronism). Your healthcare provider should check your blood pressure and potassium levels.
• liver problems. Some people who also have other serious medical problems may have severe liver problems that may lead to death, especially if you take certain doses of Noxafil or Noxafil PowderMix. Your healthcare provider should do blood tests to check your liver while you are taking Noxafil or Noxafil PowderMix. Call your healthcare provider right away if you have any of the following symptoms of liver problems:
  • itchy skin
  • nausea or vomiting
  • yellowing of your eyes or skin
  • feeling very tired
  • flu-like symptoms

• increased amounts of midazolam in your blood. If you take Noxafil or Noxafil PowderMix with midazolam, Noxafil or Noxafil PowderMix increases the amount of midazolam in your blood. This can make your sleepiness last longer. Your healthcare provider should check you closely for side effects if you take midazolam with Noxafil or Noxafil PowderMix.

The most common side effects of Noxafil in adults include:

• diarrhea
• nausea
• fever
• vomiting

• headache
• coughing
• low potassium levels in the blood

The most common side effects of Noxafil injection and Noxafil PowderMix in children include:

• fever
• fever with low white blood cell count (febrile neutropenia)
• vomiting
• redness and sores of the lining of the mouth, lips, throat, stomach, and genitals (mucositis or stomatitis)

• itching
• high blood pressure
• low potassium levels in the blood

If you take Noxafil delayed-release tablets, Noxafil oral suspension, or Noxafil PowderMix for delayed-release oral suspension, tell your healthcare provider right away if you have diarrhea or vomiting.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Noxafil or Noxafil PowderMix. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store Noxafil or Noxafil PowderMix?

Noxafil injection

• Store Noxafil injection refrigerated between 36°F to 46°F (2°C to 8°C).

Noxafil delayed-release tablets

• Store Noxafil delayed-release tablets at room temperature between 68°F to 77°F (20°C to 25°C).

Noxafil oral suspension

• Store Noxafil oral suspension at room temperature between 68°F to 77°F (20°C to 25°C).
• Do not freeze Noxafil oral suspension.

Noxafil PowderMix for delayed-release oral suspension

• Store the entire kit at room temperature between 68°F to 77°F (20°C to 25°C) in a clean, dry place.
• Do not open the foil packet until ready for use.

Safely throw away medicine that is out of date or no longer needed.

Keep Noxafil and Noxafil PowderMix and all medicines out of the reach of children.

General information about the safe and effective use of Noxafil and Noxafil PowderMix.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use Noxafil or Noxafil PowderMix for a condition for which it was not prescribed. Do not give Noxafil or Noxafil PowderMix to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about Noxafil or Noxafil PowderMix that is written for health professionals.

What are the ingredients in Noxafil and Noxafil PowderMix?
Active ingredient: posaconazole
Inactive ingredients:
Noxafil injection: Betadex Sulfobutyl Ether Sodium (SBECD), edetate sodium, hydrochloric acid, sodium hydroxide, and water for injection.
Noxafil delayed-release tablets: croscarmellose sodium, hydroxypropylcellulose, hypromellose acetate succinate, iron oxide yellow, Macrogol/PEG 3350, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol partially hydrolyzed, silicon dioxide, talc, and titanium dioxide.
Noxafil oral suspension: artificial cherry flavor, citric acid monohydrate, glycerin, liquid glucose, polysorbate 80, purified water, simethicone, sodium benzoate, sodium citrate dihydrate, titanium dioxide, and xanthan gum.
Noxafil PowderMix for delayed-release oral suspension: hypromellose acetate succinate. The mixing liquid contains: anhydrous citric acid, antifoam Af emulsion, berry citrus sweet flavor, carboxymethylcellulose sodium, carrageenan calcium sulfate trisodium phosphate, glycerin, methylparaben, microcrystalline cellulose, potassium sorbate, propylparaben, purified water, sodium citrate, sodium phosphate monobasic monohydrate, sodium saccharin, sorbitol solution, and xanthan gum.

Manuf. for: Merck Sharp & Dohme LLC
Rahway, NJ 07065, USA
For patent information: www.msd.com/research/patent
The trademarks depicted in this piece are owned by their respective companies.
Copyright © 2006-2026 Merck & Co., Inc., Rahway, NJ, USA, and its affiliates.
All rights reserved.

usppi-mk5592-mf-2601r024
For more information, go to www.noxafil.com or call 1-800-672-6372.